Fasting plasma glucose and incident heart failure risk: A population-based cohort study and new meta-analysis

Journal of Cardiac Failure

Volumn 20, Issue 8, 2014, Pages 584-592

  Khan, Hassan ^a   Kunutsor, Setor K ^a   Kauhanen, Jussi ^b   Kurl, Sudhir ^b   Gorodeski, Eiran Z ^c   Adler, Amanda I ^d   Butler, Javed ^e   Laukkanen, Jari A ^b,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c LERNER RESEARCH INSTITUTE   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e EMORY UNIVERSITY   (United States)

^f LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

diabetes; Fasting plasma glucose; heart failure; meta analysis; risk factor

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); FASTING PLASMA GLUCOSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; BLOOD; DIET RESTRICTION; HEALTH; HEALTH SURVEY; INCIDENCE; METABOLISM; RISK ASSESSMENT; RISK FACTOR;

BLOOD GLUCOSE; FASTING; FOLLOW-UP STUDIES; GLOBAL HEALTH; HEART FAILURE; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84905501363     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.05.011     Document Type: Article

References (36)

1. J.J. McMurray, and S. Stewart Epidemiology, aetiology, and prognosis of heart failure Heart 83 2000 596 602
2. W.B. Kannel, M. Hjortland, and W.P. Castelli Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34 1974 29 34
3. J.I. Barzilay, R.A. Kronmal, and J.S. Gottdiener et al. The association of fasting glucose levels with congestive heart failure in diabetic adults ≥65 years: the Cardiovascular Health Study J Am Coll Cardiol 43 2004 2236 2241
4. H.C. Gerstein, J. Pogue, J.F. Mann, E Lonn, G.R. Dagenais, and M. McQueen et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis Diabetologia 48 2005 1749 1755
5. S. Erqou, C.T. Lee, M. Suffoletto, J.B. Echouffo-Tcheuqui, R.A. de Boer, and J.P. van Melle et al. Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis Eur J Heart Fail 15 2013 185 193
6. C.Y. Zhang, A.J. Sun, S.N. Zhang, C.N. Wu, M.Q. Fu, and G. Xia et al. Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis Ann Med 42 2010 305 315
7. D. Castagno, J. Baird-Gunning, P.S. Jhund, G. Biondi-Zoccai, M.R. MacDonald, and M.C. Petrie et al. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis Am Heart J 162 2011 938 948e2
8. C. Held, H.C. Gerstein, S. Yusuf, F. Zhao, L. Hilbrich, and C. Anderson et al. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk Circulation 115 2007 1371 1375
9. E. Ingelsson, J. Sundstrom, J. Arnlov, B. Zethelius, and L. Lind Insulin resistance and risk of congestive heart failure JAMA 294 2005 334 341
10. G.A. Nichols, C.E. Koro, and N.S. Kolatkar The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose J Diabetes Complications 23 2009 224 228
11. A. Kalogeropoulos, V. Georgiopoulou, T.B. Harris, S.B. Kritchevsky, D.C. Bauer, and A.L. Smith et al. Glycemic status and incident heart failure in elderly without history of diabetes mellitus: the health, aging, and body composition study J Card Fail 15 2009 593 599
12. J.T. Salonen Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study Ann Clin Res 20 1988 46 50
13. J.T. Salonen, K. Nyyssonen, H. Korpela, J. Tuomilehto, R. Seppanen, and R. Salonen High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men Circulation 86 1992 803 811
14. M. Sokolow, and T.P. Lyon The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads 1949 Ann Noninvasive Electrocardiol 6 2001 343 368
15. P.M. Okin, M.J. Roman, R.B. Devereux, T.G. Pickering, J.S. Borer, and P. Kligfield Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy Hypertension 31 1998 937 942
16. J. Karppi, S. Kurl, T.H. Makikallio, K. Ronkainen, and J.A. Laukkanen Serum beta-carotene concentrations and the risk of congestive heart failure in men: a population-based study Int J Cardiol 168 2013 1841 1846
17. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
18. D.F. Easton, J. Peto, and A.G. Babiker Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group Stat Med 10 1991 1025 1035
19. N. Sarwar, J. Danesh, G. Eiriksdottir, G. Sigurdsson, N. Wareham, and S. Bingham et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies Circulation 115 2007 450 458
20. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
21. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
22. S.G. Thompson, and S.J. Sharp Explaining heterogeneity in meta-analysis: a comparison of methods Stat Med 18 1999 2693 2708
23. S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
24. K. Matsushita, S. Blecker, A. Pazin-Filho, A. Bertoni, P.P. Chang, and J. Coresh et al. The association of hemoglobin A1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study Diabetes 59 2010 2020 2026
25. H. Bahrami, D.A. Bluemke, R. Kronmal, A.G. Bertoni, D.M. Lloyd-Jones, and E. Shahar et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 51 2008 1775 1783
26. C. Nielson, and T. Lange Blood glucose and heart failure in nondiabetic patients Diabetes Care 28 2005 607 611
27. I.S. Thrainsdottir, T. Aspelund, V. Gudnason, K. Malmberg, G. Sigurdsson, and G. Thorgeirsson et al. Increasing glucose levels and BMI predict future heart failure experience from the Reykjavik Study Eur J Heart Fail 9 2007 1051 1057
28. G. Basta, A.M. Schmidt, and R. de Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 2004 582 592
29. M.K. Rutter, H. Parise, E.J. Benjamin, D. Levy, M.G. Larson, and J.B. Meigs et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study Circulation 107 2003 448 454
30. P. Devos, R. Chiolero, G. van den Berghe, and J.C. Preiser Glucose, insulin and myocardial ischaemia Curr Opin Clin Nutr Metab Care 9 2006 131 139
31. A. Holmang, N. Yoshida, E. Jennische, A. Waldenstrom, and P. Bjorntorp The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats Eur J Clin Invest 26 1996 973 978
32. E.A. Anderson, R.P. Hoffman, T.W. Balon, C.A. Sinkey, and A.L. Mark Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans J Clin Invest 87 1991 2246 2252
33. L.D. Grossman, G. Parlan, A.L. Bailey, G. Yee, M. Yu, and J.Y. Chan Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years Clin Ther 31 2009 74 88
34. M. Komajda, J.J. McMurray, H. Beck-Nielsen, R. Gomis, M. Hanefeld, and S.J. Pocock et al. Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial Eur Heart J 31 2010 824 831
35. G. Davey Smith, and S. Ebrahim "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32 2003 1 22
36. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, and A. Haouzi et al. Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269